Hemorrhagic choroidal detachment as the presenting sign of uveal melanoma
Yewlin E. Chee Raghu Mudumbai Steven S. Saraf Thellea Leveque Verena S. Grieco Monique A. Mogensen Rebecca A. Yoda Luis F. Gonzalez-Cuyar Andrew W. Stacey
Andrew Stacey
Stacey Andrew / Andrew W Stacey
ORCID: 0000-0002-4441-6302
The Effects of Breastfeeding on Retinoblastoma Development: Results from an International Multicenter Retinoblastoma Survey 10.3390/cancers13194773
Adjuvant use of laser in eyes with macular retinoblastoma treated with primary intravenous chemotherapy 10.1136/bjophthalmol-2020-316862
The addition of topotecan to melphalan in the treatment of retinoblastoma with intra-arterial chemotherapy 10.1016/j.oret.2020.11.007
Incidence of retinoblastoma has increased: results from 40 European countries 10.1016/j.ophtha.2021.01.024
Lag Time between Onset of First Symptom and Treatment of Retinoblastoma: An International Collaborative Study of 692 Patients from 10 Countries 10.3390/cancers13081956
Hemorrhagic choroidal detachment as the presenting sign of uveal melanoma 10.1016/j.ajoc.2021.101173
Luis Gonzalez-Cuyar
Gonzalez-Cuyar Luis
ORCID: 0000-0002-8424-8331
Kinome and phosphoproteome of high-grade meningiomas reveal AKAP12 as a central regulator of aggressiveness and its possible role in progression 10.1038/s41598-018-19308-y
Chimeric Antigen Receptor T Cell–Mediated Neurotoxicity in Nonhuman Primates 10.1158/2159-8290.CD-17-1368
From cells to tissue: How cell scale heterogeneity impacts glioblastoma growth and treatment response 10.1101/650150
Cellular respiration and tumor suppressor genes 10.1007/978-1-59745-435-3_10
Gadolinium tissue deposition in brain and bone 10.1016/j.mri.2016.08.025
Redox active iron accumulation in aceruloplasminemia 10.1111/j.1440-1789.2008.00901.x
Macrocyclic and other non-group 1 gadolinium contrast agents deposit low levels of gadolinium in brain and bone tissue: Preliminary results from 9 patients with normal renal function 10.1097/RLI.0000000000000252
Role of cerebrospinal fluid and plasma biomarkers in the diagnosis of neurodegenerative disorders and mild cognitive impairment 10.1007/s11910-011-0212-0
Neutral lipid storage disease with myopathy: Further phenotypic characterization of a rare PNPLA2 variant 10.1016/j.nmd.2018.04.010
Monomorphic post-transplant lymphoproliferative disorder of the tongue: Case report and review of literature 10.1186/1746-1596-2-49
Giant Pediatric Rhabdoid Meningioma Associated with a Germline BAP1 Pathogenic Variation: A Rare Clinical Case 10.1016/j.wneu.2018.06.227
Salivary tau species are potential biomarkers of alzheimer's disease 10.3233/JAD-2011-110731
Multiplex immunoassays of peptide hormones extracted from formalin-fixed, paraffin-embedded tissue accurately subclassify pituitary adenomas 10.1373/clinchem.2011.170613
Primary Gliosarcoma of the Optic Nerve: A Unique Adult Optic Pathway Glioma 10.1097/IOP.0000000000000798
Cheek cell-derived α-synuclein and DJ-1 do not differentiate Parkinson's disease from control 10.1016/j.neurobiolaging.2013.08.008
Cerebrotendinous xanthomatosis: Case report with evidence of oxidative stress 10.1179/135100007X200173
Somatic PDGFRB Activating Variants in Fusiform Cerebral Aneurysms 10.1016/j.ajhg.2019.03.014
Novel antibody capture assay for paraffin-embedded tissue detects wide-ranging amyloid beta and paired helical filament-tau accumulation in cognitively normal older adults 10.1111/j.1750-3639.2011.00542.x
Cerebrotendinous xanthomatosis: A critical update 10.2217/14796708.3.4.491
Fatal parvoviral myocarditis: A case report and review of literature 10.1186/1746-1596-3-21
Clival paragangliomas: a report of two cases involving the midline skull base and review of the literature 10.1007/s11060-017-2396-x
Angiolymphoid hyperplasia with eosinophilia developing in a patient with history of peripheral T-cell lymphoma: Evidence for multicentric T-cell lymphoproliferative process 10.1186/1746-1596-3-22
Alternative splicing in a presenilin 2 variant associated with Alzheimer disease 10.1002/acn3.755
Plasmablastic lymphoma of the oral cavity: a rapidly progressive lymphoma associated with HIV infection 10.1016/S1473-3099(08)70067-7
Application of the condensed protocol for the NIA-AA guidelines for the neuropathological assessment of Alzheimer's disease in an academic clinical practice 10.1111/his.13345
Lack of BRAF-V600E Mutation in Papillary Tumor of the Pineal Region 10.1227/NEU.0000000000000877
Gene therapy enhances chemotherapy tolerance and efficacy in glioblastoma patients 10.1172/JCI76739
Distinct Phenotypic Clusters of Glioblastoma Growth and Response Kinetics Predict Survival 10.1200/CCI.17.00080
Cerebral cortical Aβ 42 and PHF-τ in 325 consecutive brain autopsies stratified by diagnosis, location, and APOE 10.1097/NEN.0000000000000153
Comparative Proteomic Profiling Using Two-Dimensional Gel Electrophoresis and Identification via LC-MS/MS Reveals Novel Protein Biomarkers to Identify Aggressive Subtypes of WHO Grade i Meningioma 10.1055/s-0037-1601889
Sodium polystyrene sulfonate (Kayexalate) aspiration 10.1186/1746-1596-3-27
In the Eye of the Beholder: A Conjunctival Lesion in a Woman with Acute Myelogenous Leukemia 10.1093/cid/ciy394
Deep sequencing of multiple regions of glial tumors reveals spatial heterogeneity for mutations in clinically relevant genes 10.1186/s13059-014-0530-z
Extra-oral plasmablastic lymphoma: report of a case and review of literature 10.1016/j.humpath.2006.04.009
Quantitative neuropathology associated with chronic manganese exposure in South African mine workers 10.1016/j.neuro.2013.12.008
Neuropathological Comparison of Adult Onset and Juvenile Huntington's Disease with Cerebellar Atrophy: A Report of a Father and Son 10.3233/JHD-170261
Effects of tumor grade and dexamethasone on myeloid cells in patients with glioma 10.1080/2162402X.2018.1507668
Ex vivo magnetic resonance imaging in South African manganese mine workers 10.1016/j.neuro.2015.04.002
Bilateral internal carotid absence: a case report of a rare congenital anomaly 10.1016/j.carpath.2007.04.009
Endothelial activation and blood–brain barrier disruption in neurotoxicity after adoptive immunotherapy with CD19 CAR-T cells 10.1158/2159-8290.CD-17-0698
Sudden unexpected death in lymphocytic hypophysitis 10.1097/PAF.0b013e3181873851
Phosphoproteomic and Kinomic Signature of Clinically Aggressive Grade I (1.5) Meningiomas Reveals RB1 Signaling as a Novel Mediator and Biomarker. 10.1158/1078-0432.ccr-18-0641
ENvironmental Dynamics Underlying Responsive Extreme Survivors (ENDURES) of Glioblastoma: A Multidisciplinary Team-based, Multifactorial Analytical Approach. 10.1097/coc.0000000000000564
From Herniation to Rehabilitation: A Young Woman With Rapidly Progressive Neurological Deficits. 10.1177/1941874419832437
Hyperphosphorylated Tau, Increased Adenylate Cyclase 5 (ADCY5) Immunoreactivity, but No Neuronal Loss in ADCY5‐Dyskinesia 10.1002/mdc3.12873
Intraoperative assessment of skull base tumors using stimulated Raman scattering microscopy 10.1038/s41598-019-56932-8
From cells to tissue: How cell scale heterogeneity impacts glioblastoma growth and treatment response 10.1371/journal.pcbi.1007672
Effect of formalin fixation on measured concentrations of deposited gadolinium in human tissue: an autopsy study 10.1177/0284185121994047
Comparison of Human Tissue Gadolinium Retention and Elimination between Gadoteridol and Gadobenate 10.1148/radiol.2021204320
Operational Impacts of the Coronavirus Disease 2019 (COVID-19) Pandemic and Early Recovery Trends: University of Washington Anatomic Pathology Experience 10.5858/arpa.2020-0639-sa
Rapid Validation of Telepathology by an Academic Neuropathology Practice During the COVID-19 Pandemic 10.5858/arpa.2020-0372-sa
Variability in hair gadolinium concentrations among decedents who received gadolinium-based contrast agents 10.1007/s00216-020-03116-3
Human Hair as a Possible Surrogate Marker of Retained Tissue Gadolinium 10.1097/rli.0000000000000681
Sex-specific impact of patterns of imageable tumor growth on survival of primary glioblastoma patients 10.1186/s12885-020-06816-2
Hemorrhagic choroidal detachment as the presenting sign of uveal melanoma 10.1016/j.ajoc.2021.101173